Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2017 Sep;57(3):481-485.
doi: 10.1007/s12020-017-1370-x. Epub 2017 Jul 12.

Cushing's syndrome: a model for sarcopenic obesity

Affiliations
Comparative Study

Cushing's syndrome: a model for sarcopenic obesity

Michael Drey et al. Endocrine. 2017 Sep.

Abstract

Purpose: Obesity and its metabolic impairments are discussed as major risk factors for sarcopenia leading to sarcopenic obesity. Cushing's syndrome is known to be associated with obesity and muscle atrophy. We compared Cushing's syndrome with matched obese controls regarding body composition, physical performance, and biochemical markers to test the hypothesis that Cushing's syndrome could be a model for sarcopenic obesity.

Methods: By propensity score matching, 47 controls were selected by body mass index and gender as obese controls. Fat mass and muscle mass were measured by bioelectrical impedance analysis. Muscle function was assessed by chair rising test and hand grip strength. Biochemical markers of glucose and lipid metabolism and inflammation (hsCRP) were measured in peripheral blood.

Results: Muscle mass did not differ between Cushing's syndrome and obese controls. However, Cushing's syndrome patients showed significantly greater chair rising time (9.5 s vs. 7.3 s, p = 0.008) and significantly lower hand grip strength (32.1 kg vs. 36.8 kg, p = 0.003). Cushing's syndrome patients with impaired fasting glucose have shown the highest limitations in hand grip strength and chair rising time.

Conclusions: Similar to published data in ageing medicine, Cushing's syndrome patients show loss of muscle function that cannot be explained by loss of muscle mass. Impaired muscle quality due to fat infiltration may be the reason. This is supported by the observation that Cushing's syndrome patients with impaired glucose metabolism show strongest deterioration of muscle function. Research in sarcopenic obesity in elderly is hampered by confounding comorbidities and polypharmacy. As Cushing's syndrome patients are frequently free of comorbidities and as Cushing's syndrome is potentially curable we suggest Cushing's syndrome as a clinical model for further research in sarcopenic obesity.

Keywords: Cushing’s syndrome; Frailty; Obesity; Sarcopenia; Sarcopenic obesity.

PubMed Disclaimer

References

    1. Eur J Clin Invest. 2015 Feb;45(2):126-34 - PubMed
    1. Endocrine. 2017 Feb;55(2):456-469 - PubMed
    1. Clin Geriatr Med. 2010 May;26(2):331-46 - PubMed
    1. Eur J Endocrinol. 2014 Aug;171(2):209-15 - PubMed
    1. Biogerontology. 2015 Feb;16(1):15-29 - PubMed

MeSH terms

LinkOut - more resources